Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid for prevention of AI-associated musculoskeletal symptoms
NCT01194440Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Feb 2011
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zoledronic acid, sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Feb 2011; status: completed.
02
Drugs
zoledronic acid
Beyond the preview
Go deeper on NCT01194440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01194440.